KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cvs Health (CVS) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to 2.0%.

  • Cvs Health's EBITDA Margin fell 4300.0% to 2.0% in Q4 2025 from the same period last year, while for Dec 2025 it was 1.16%, marking a year-over-year decrease of 11300.0%. This contributed to the annual value of 1.16% for FY2025, which is 11300.0% down from last year.
  • Cvs Health's EBITDA Margin amounted to 2.0% in Q4 2025, which was down 4300.0% from 3.12% recorded in Q3 2025.
  • In the past 5 years, Cvs Health's EBITDA Margin ranged from a high of 5.96% in Q2 2021 and a low of 4.83% during Q3 2022
  • Its 5-year average for EBITDA Margin is 2.89%, with a median of 3.58% in 2023.
  • Per our database at Business Quant, Cvs Health's EBITDA Margin tumbled by -89800bps in 2022 and then soared by 89400bps in 2023.
  • Cvs Health's EBITDA Margin (Quarter) stood at 3.06% in 2021, then skyrocketed by 42bps to 4.36% in 2022, then fell by -18bps to 3.6% in 2023, then plummeted by -33bps to 2.42% in 2024, then dropped by -18bps to 2.0% in 2025.
  • Its EBITDA Margin stands at 2.0% for Q4 2025, versus 3.12% for Q3 2025 and 2.41% for Q2 2025.